Evidence map›Paper›PMID 40612337›Full record

ArticleFrontiers in oncology2025

Preliminary investigation on predicting postoperative glioma recurrences based on a multiparametric radiomics model.

Fang-Xiong Fu, Guo Li, Lan Hong, Wang-Sheng Chen

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fang-Xiong Fu *Department of Radiology, Hainan General Hospital (Hainan Medical University Hainan Hospital), Haikou, China.
Guo Li *Department of Radiology, Hainan General Hospital (Hainan Medical University Hainan Hospital), Haikou, China.
Lan HongDepartment of Gynecology, Hainan General Hospital (Hainan Medical University Hainan Hospital), Haikou, China.
Wang-Sheng ChenDepartment of Radiology, Hainan General Hospital (Hainan Medical University Hainan Hospital), Haikou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The early prediction of postoperative recurrence and high recurrence area of gliomas is important for individualized clinical treatment. This study aimed to evaluate the performance of a magnetic resonance imaging (MRI)-based multiparametric radiomics model for the early prediction of postoperative recurrences. Methods: The data from 60 patients who met the inclusion criteria between 2000 and 2021 were collected in this study. Radiological features were extracted from the T1-weighted imaging (T1WI) and T2WI/fluid-attenuated inversion recovery sequence images. The multiparametric model was composed of two classifiers, the support vector machine and the logistic regression (LR), and it was used for training and prediction. The highest scoring classifiers and sequences were screened out according to the area under the curve (AUC) and accuracy. Results: For predicting the postoperative recurrences and high recurrence areas of gliomas, the performance of the LR classifier was most stable, and the multiparametric model based on clinical information, basic imaging, and radiomics had the best performance (AUC: 0.99; Accuracy: 0.96). Conclusion: The MRI-based multiparametric radiomics method provided a non-invasive, stable, and relatively accurate method for the early prediction of postoperative recurrences, which has guiding importance for individualized clinical treatment.

Indexed as

gliomaindividualized clinical treatmentmagnetic resonance imagingradiomicsrelapse

Identifiers

PMID40612337
PMCPMC12221908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.